Brief: Plus Therapeutics Q1 Net Income USD -3.261 Million
15/05/2024 21:15
May 15 (Reuters) - Plus Therapeutics Q1 basic EPS USD -0.75. * Q1 operating income USD -3.299 million * Q1 operating expenses USD 4.976 million
Recent news on Cerenome
See all newsBrief: Cerenome Secures In-Network Agreement With Florida Blue For Cnside® Csf Tumor Cell Enumeration And Molecular Profile Tests
Plus Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Cerenome Secures In-Network Agreement With Health Care Service Corporation
Plus Therapeutics Inc expected to post a loss of 91 cents a share - Earnings Preview
Brief: Plus Therapeutics Secures Regional Coverage Agreement With Medical Mutual For CNSide Cerebrospinal Fluid Assay For Metastatic CNS Cancer